[go: up one dir, main page]

LT3965884T - Thr-beta moduliatoriai su diokso-1,2,4-triazilo galine grupe - Google Patents

Thr-beta moduliatoriai su diokso-1,2,4-triazilo galine grupe

Info

Publication number
LT3965884T
LT3965884T LTEPPCT/US2020/031904T LTUS2020031904T LT3965884T LT 3965884 T LT3965884 T LT 3965884T LT US2020031904 T LTUS2020031904 T LT US2020031904T LT 3965884 T LT3965884 T LT 3965884T
Authority
LT
Lithuania
Prior art keywords
triazyl
dioxo
thr
modulators
beta
Prior art date
Application number
LTEPPCT/US2020/031904T
Other languages
English (en)
Inventor
Koen Vandyck
Pierre Raboisson
David Mcgowan
Jerome Deval
Original Assignee
Aligos Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aligos Therapeutics, Inc. filed Critical Aligos Therapeutics, Inc.
Publication of LT3965884T publication Critical patent/LT3965884T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
LTEPPCT/US2020/031904T 2019-05-08 2020-05-07 Thr-beta moduliatoriai su diokso-1,2,4-triazilo galine grupe LT3965884T (lt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962845252P 2019-05-08 2019-05-08
US201962944052P 2019-12-05 2019-12-05
US202063005661P 2020-04-06 2020-04-06
PCT/US2020/031904 WO2020227549A1 (en) 2019-05-08 2020-05-07 MODULATORS OF THR-β AND METHODS OF USE THEREOF

Publications (1)

Publication Number Publication Date
LT3965884T true LT3965884T (lt) 2025-04-10

Family

ID=70919081

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2020/031904T LT3965884T (lt) 2019-05-08 2020-05-07 Thr-beta moduliatoriai su diokso-1,2,4-triazilo galine grupe

Country Status (32)

Country Link
US (3) US11091467B2 (lt)
EP (2) EP3965884B1 (lt)
JP (2) JP7574223B2 (lt)
KR (1) KR20220017917A (lt)
CN (1) CN114096531A (lt)
AU (1) AU2020267576B2 (lt)
BR (1) BR112021021718A2 (lt)
CA (1) CA3139101A1 (lt)
CL (1) CL2021002883A1 (lt)
CO (1) CO2021015698A2 (lt)
DK (1) DK3965884T3 (lt)
ES (1) ES3020290T3 (lt)
FI (1) FI3965884T3 (lt)
GE (2) GEAP202415821A (lt)
HR (1) HRP20250384T1 (lt)
HU (1) HUE070650T2 (lt)
IL (1) IL287720A (lt)
LT (1) LT3965884T (lt)
MA (1) MA55890B1 (lt)
MD (1) MD3965884T2 (lt)
MX (1) MX2021013472A (lt)
MY (1) MY210357A (lt)
PE (1) PE20220255A1 (lt)
PH (1) PH12021552782A1 (lt)
PL (1) PL3965884T3 (lt)
PT (1) PT3965884T (lt)
RS (1) RS66686B1 (lt)
SG (1) SG11202111552YA (lt)
SI (1) SI3965884T1 (lt)
TW (1) TWI855068B (lt)
WO (1) WO2020227549A1 (lt)
ZA (1) ZA202409114B (lt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121081472A (zh) 2018-12-13 2025-12-09 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
KR20220017917A (ko) * 2019-05-08 2022-02-14 알리고스 테라퓨틱스 인코포레이티드 Thr-베타의 조절제 및 이의 사용 방법
EP4017875A4 (en) * 2019-08-23 2023-05-03 Terns Pharmaceuticals, Inc. THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
JP2022548250A (ja) 2019-09-12 2022-11-17 ターンズ・ファーマシューティカルズ・インコーポレイテッド 甲状腺ホルモン受容体ベータアゴニスト化合物
WO2021104288A1 (zh) * 2019-11-26 2021-06-03 昆药集团股份有限公司 1，2，4-三嗪-3，5-二酮类化合物及其制备方法和应用
CN114787153A (zh) 2019-12-26 2022-07-22 苏州科睿思制药有限公司 一种Resmetirom晶型及其制备方法和用途
CN113278013B (zh) * 2020-02-20 2022-09-23 昆药集团股份有限公司 2,6-二取代的1,2,4-三嗪-3,5-二酮化合物及其制备方法和应用
EP4159723B1 (en) * 2020-06-02 2025-07-23 Chengdu Kanghong Pharmaceutical Co., Ltd. Novel thyroid hormone beta receptor agonist
WO2021257851A1 (en) 2020-06-17 2021-12-23 Autobahn Therapeutics, Inc. Thyromimetics
CA3192243A1 (en) * 2020-09-10 2022-03-17 Crystal Pharmaceutical (Suzhou) Co., Ltd. Crystal form of resmetirom, preparation method therefor, and use thereof
WO2022053028A1 (zh) * 2020-09-10 2022-03-17 南京明德新药研发有限公司 1,2,4-三嗪-3,5(2h,4h)-二酮类化合物及其应用
US20240025875A1 (en) * 2020-09-17 2024-01-25 Sunshine Lake Pharma Co., Ltd. A compound as a thyroid hormone beta receptor agonist and use thereof
KR20230123929A (ko) * 2020-11-06 2023-08-24 알리고스 테라퓨틱스 인코포레이티드 갑상선 수용체 작용제로서의 피리다지논 유도체 및 이의 용도
JP2023548541A (ja) * 2020-11-06 2023-11-17 アリゴス セラピューティクス，インコーポレーテッド オキシインドール及びその使用方法
CN114591300A (zh) * 2020-12-04 2022-06-07 南京圣和药业股份有限公司 作为THRβ激动剂的杂环化合物及其应用
CN112645936B (zh) * 2020-12-17 2022-03-01 山东第一医科大学(山东省医学科学院) 取代的哒嗪酮类化合物及其用途
CN114685450A (zh) * 2020-12-30 2022-07-01 昆药集团股份有限公司 2-吡啶酮类衍生物及其制备方法和在医药上的应用
CN114907327A (zh) * 2021-02-10 2022-08-16 杭州领业医药科技有限公司 Resmetirom的晶型及其制备方法和用途
CA3212130A1 (en) * 2021-03-03 2022-09-09 Terns Pharmaceuticals, Inc. Thyroid hormone receptor beta agonist compounds
US20240083860A1 (en) * 2021-03-04 2024-03-14 Fukang (Shanghai) Health Technology Co., Ltd Aromatic compound, preparation method therefor, and application thereof
CN115073429A (zh) * 2021-03-15 2022-09-20 昆药集团股份有限公司 一种1，2，4-三嗪-3，5-二酮类化合物的盐型、晶型及其制备方法
CN117279911B (zh) * 2021-05-21 2025-07-08 深圳微芯生物科技股份有限公司 一种杂环化合物及其应用
WO2023023474A1 (en) * 2021-08-16 2023-02-23 Senya Pharmaceuticals, Inc. Tr-beta modulators, pharmaceutical compositions, and therapeutic applications
US20250243491A1 (en) 2021-09-01 2025-07-31 Aligos Therapeutics, Inc. Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof
JP2024533262A (ja) 2021-09-08 2024-09-12 アリゴス セラピューティクス，インコーポレーテッド 修飾された短鎖干渉核酸（ｓｉｎａ）分子及びその使用
CN116354934A (zh) * 2021-12-28 2023-06-30 中国科学院上海药物研究所 一类喹啉类化合物及其制备方法、药物组合物和用途
CN115650928B (zh) * 2022-12-28 2023-03-31 凯思凯旭(上海)医药科技有限公司 一种多环类甲状腺激素β受体激动剂及其用途
WO2024182446A2 (en) 2023-02-28 2024-09-06 Aligos Therapeutics, Inc. Pnpla3-targeting short interfering rna (sirna) molecules and uses thereof
AU2024231381A1 (en) 2023-03-07 2025-09-18 Aligos Therapeutics, Inc. Modified short interfering nucleic acid (siNA) molecules and uses thereof
US20240398794A1 (en) 2023-04-07 2024-12-05 Terns Pharmaceuticals, Inc. COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF
CN121358734A (zh) * 2023-06-19 2026-01-16 西威埃医药技术（上海）有限公司 THR-β受体激动剂、其制备方法和其使用方法
WO2025011259A1 (zh) * 2023-07-07 2025-01-16 苏州科睿思制药有限公司 瑞司美替罗的晶型及其制备方法和用途
CN117327057A (zh) * 2023-08-30 2024-01-02 南京雷正医药科技有限公司 一类作为甲状腺激素受体激动剂的三嗪二酮类化合物及其合成、用途
WO2025137568A1 (en) * 2023-12-21 2025-06-26 Aligos Therapeutics, Inc. Modulators of thr-beta and methods of use thereof
US20250340541A1 (en) 2024-05-03 2025-11-06 Aligos Therapeutics, Inc. Methods of preparing modulators of thr-beta
WO2025252147A1 (zh) * 2024-06-07 2025-12-11 珠海联邦制药股份有限公司 一种甲状腺激素β受体激动剂的化合物及其应用
CN120923503A (zh) * 2025-10-10 2025-11-11 吉斯凯(苏州)制药有限公司 具有杂环结构的化合物、THRβ受体激动剂及用途

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
PT1088819E (pt) * 1999-09-30 2005-09-30 Pfizer Prod Inc Derivados de 6-azauracilo como lignados de receptores da tiroide
GB0015205D0 (en) 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
ATE337009T1 (de) 2001-05-31 2006-09-15 Pfizer Prod Inc Medizinische verwendung thyromimetischer verbindungen gegen haarausfall und zusammensetzungen
WO2003064369A1 (en) 2002-01-30 2003-08-07 Kissei Pharmaceutical Co., Ltd. Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
NZ537752A (en) 2002-07-29 2006-12-22 Rigel Pharmaceuticals Inc Use of 2,4-pyrimidinediamine compounds in the preparation of medicaments for treating autoimmune diseases
WO2004047827A1 (en) 2002-11-25 2004-06-10 Pfizer Products Inc. Method for promoting nail growth using thyromimetic compounds
CN101228135B (zh) * 2005-07-21 2011-08-31 霍夫曼-拉罗奇有限公司 作为甲状腺激素受体激动剂的哒嗪酮衍生物
KR20080087833A (ko) * 2005-12-21 2008-10-01 쉐링 코포레이션 히스타민 ｈ３ 길항제로서 유용한 페녹시피페리딘 및 이의유사체
CA2655913A1 (en) * 2006-06-28 2008-01-03 Sanwa Kagaku Kenkyusho Co., Ltd. Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility
WO2008104752A1 (en) * 2007-02-26 2008-09-04 Astrazeneca Ab Dihydropyridones as elastase inhibitors
US8076334B2 (en) * 2007-09-20 2011-12-13 Hoffmann-La Roche Inc. Prodrugs of thyroid hormone analogs
US8791266B2 (en) 2009-04-20 2014-07-29 Mitsubishi Tanabe Pharma Corporation Thyroid hormone β receptor agonist
JP5847533B2 (ja) 2010-10-19 2016-01-27 田辺三菱製薬株式会社 新規甲状腺ホルモンβ受容体作動薬
EP2695611B1 (en) 2012-08-06 2014-10-01 Dr. August Wolff GmbH & Co. KG Arzneimittel Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
ES2907926T3 (es) * 2012-09-17 2022-04-27 Madrigal Pharmaceuticals Inc Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos
US20160158200A1 (en) 2013-07-09 2016-06-09 Bristol-Myers Squibb Company Combinations of Hepatitis C Virus Inhibitors
US10303567B2 (en) 2013-08-15 2019-05-28 Entit Software Llc Managing database nodes
GB201318793D0 (en) 2013-10-24 2013-12-11 Plaquetec Ltd Vascular Biomarkers
HK1243369A1 (zh) 2015-01-09 2018-07-13 吉利德阿波罗公司 用於治疗非酒精性脂肪肝病的acc抑制剂组合治疗
WO2017210526A1 (en) 2016-06-03 2017-12-07 Chemocentryx, Inc. Method of treating liver fibrosis
CN110167557A (zh) 2016-10-18 2019-08-23 马德里加尔制药公司 用thr-beta兴奋剂治疗肝脏疾病或脂质疾病的方法
IL268751B (en) 2017-03-13 2022-08-01 Genfit Pharmaceutical preparations for combined treatment
KR102699958B1 (ko) 2017-04-18 2024-08-29 장피트 엘라피브라노르와 같은 ppar 작용제 및 아세틸-coa 카르복실라아제 (acc) 저해제를 포함하는 조합
US10857144B2 (en) 2017-05-16 2020-12-08 Bow River LLC Methods of treatment
US11808772B2 (en) 2017-07-19 2023-11-07 Bio-Rad Europe Gmbh Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status
WO2019099457A1 (en) 2017-11-14 2019-05-23 Quixgen, Inc. Benzodioxinone compounds
SG11202005007VA (en) 2017-12-06 2020-06-29 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
JP7156722B2 (ja) 2018-01-23 2022-10-19 深▲チェン▼市塔吉瑞生物医薬有限公司 置換ピリダジノン化合物
EP3765059A4 (en) 2018-03-12 2022-01-12 Yale University METHODS OF TREATMENT OR PREVENTION OF ACUTE RESPIRATORY SYNDROME
WO2019213611A1 (en) 2018-05-04 2019-11-07 Cirius Therapeutics, Inc. Thiazolidinedione analogs for the treatment of nafld and metabolic diseases
CN108727344A (zh) 2018-05-14 2018-11-02 嘉兴特科罗生物科技有限公司 一种化合物及其合成方法和应用
MX2020011562A (es) 2018-06-12 2021-02-02 Sichuan Haisco Pharmaceutical Co Ltd Agonistas del receptor de la hormona tiroidea y usos de los mismos.
CN112367979B (zh) 2018-06-14 2024-05-03 博洛尼亚大学 用于局部释放抗炎药和促髓鞘药的电纺纤维
WO2019242766A1 (zh) 2018-06-22 2019-12-26 成都海创药业有限公司 氘代mgl-3196化合物及其用途
TW202019914A (zh) 2018-07-02 2020-06-01 美商瑪德瑞高製藥公司 ２-（３，５-二氯-４-（（５-異丙基-６-側氧基-１，６-二氫噠嗪-３-基）氧）苯基）-３，５-二側氧基-２，３，４，５-四氫-１，２，４-三嗪-６-腈之固體型式
TWI825144B (zh) 2018-08-10 2023-12-11 美商思達利醫藥公司 第二型轉麩醯胺酸酶(tg2)抑制劑
EP3840755A4 (en) 2018-08-24 2022-04-20 Terns, Inc. THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
TWI884745B (zh) 2018-10-12 2025-05-21 美商拓臻股份有限公司 甲狀腺素受體β促效劑化合物
US12391677B2 (en) 2018-10-12 2025-08-19 InventisBio Co., Ltd. Thyroid hormone receptor agonists
CN121081472A (zh) 2018-12-13 2025-12-09 拓臻股份有限公司 一种THRβ受体激动剂化合物及其制备方法和用途
EP3927693A4 (en) 2019-02-21 2023-04-05 Nanjing Ruijie Pharma Co., Ltd. NOVEL COMPOUNDS AND THEIR USES AS THYROID HORMONE RECEPTOR AGONISTS
KR20220017917A (ko) * 2019-05-08 2022-02-14 알리고스 테라퓨틱스 인코포레이티드 Thr-베타의 조절제 및 이의 사용 방법
TW202108556A (zh) 2019-05-10 2021-03-01 大陸商深圳微芯生物科技股份有限公司 一種噠嗪酮衍生物及其應用
IT201900006923A1 (it) 2019-05-16 2020-11-16 International Soc For Drug Development S R L Nuovi tiromimetici con uno scaffold bifenilmetano e loro uso
WO2020239076A1 (zh) 2019-05-29 2020-12-03 南京明德新药研发有限公司 作为甲状腺素受体-β激动剂的哒嗪酮类衍生物及其应用
CN112300133B (zh) 2019-07-31 2024-07-30 深圳微芯生物科技股份有限公司 一种杂环化合物及其应用
AU2020334943A1 (en) 2019-08-19 2022-03-10 Hepagene Therapeutics (HK) Limited Heterocyclic THR-β receptor agonist compound and preparation method and use therefor
CN112409340B (zh) 2019-08-21 2022-03-18 海创药业股份有限公司 卤素取代的苯醚类化合物及其用途
EP4017875A4 (en) 2019-08-23 2023-05-03 Terns Pharmaceuticals, Inc. THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
WO2021043185A1 (en) 2019-09-04 2021-03-11 Sunshine Lake Pharma Co., Ltd. A compound as a thyroid hormone beta receptor agonist and use thereof
JP2022548250A (ja) 2019-09-12 2022-11-17 ターンズ・ファーマシューティカルズ・インコーポレイテッド 甲状腺ホルモン受容体ベータアゴニスト化合物
WO2021057791A1 (zh) 2019-09-24 2021-04-01 广东东阳光药业有限公司 一种作为甲状腺激素Beta受体激动剂的化合物及其用途
CN112707892A (zh) 2019-10-24 2021-04-27 苏州泽璟生物制药股份有限公司 哒嗪酮或哒嗪类化合物及其衍生物和药物组合物
WO2021104288A1 (zh) 2019-11-26 2021-06-03 昆药集团股份有限公司 1，2，4-三嗪-3，5-二酮类化合物及其制备方法和应用
US11780825B2 (en) 2020-01-13 2023-10-10 Eccogene (Shanghai) Co., Ltd. Thyroid hormone receptor agonists and use thereof
AU2021251335A1 (en) 2020-04-06 2022-10-27 Basf Se Imidazo-pyrimidone compounds as pesticides

Also Published As

Publication number Publication date
US20200354345A1 (en) 2020-11-12
MY210357A (en) 2025-09-13
JP2022532706A (ja) 2022-07-19
HUE070650T2 (hu) 2025-06-28
KR20220017917A (ko) 2022-02-14
HRP20250384T1 (hr) 2025-05-23
JP7574223B2 (ja) 2024-10-28
WO2020227549A8 (en) 2021-05-27
PH12021552782A1 (en) 2023-01-16
US20250304561A1 (en) 2025-10-02
EP3965884A1 (en) 2022-03-16
FI3965884T3 (fi) 2025-04-02
EP4523692A2 (en) 2025-03-19
PE20220255A1 (es) 2022-02-16
ZA202409114B (en) 2025-06-25
US11091467B2 (en) 2021-08-17
US12180192B2 (en) 2024-12-31
AU2020267576A1 (en) 2021-12-09
WO2020227549A1 (en) 2020-11-12
TW202108569A (zh) 2021-03-01
MA55890A (fr) 2022-03-16
RS66686B1 (sr) 2025-05-30
EP3965884B1 (en) 2025-01-15
EP4523692A3 (en) 2025-06-04
DK3965884T3 (da) 2025-03-31
GEP20247637B (en) 2024-06-25
GEAP202415821A (en) 2024-03-11
MA55890B1 (fr) 2025-03-28
CA3139101A1 (en) 2020-11-12
IL287720A (en) 2021-12-01
MX2021013472A (es) 2022-01-06
PL3965884T3 (pl) 2025-05-05
ES3020290T3 (en) 2025-05-22
CN114096531A (zh) 2022-02-25
CO2021015698A2 (es) 2022-01-17
SI3965884T1 (sl) 2025-05-30
PT3965884T (pt) 2025-03-31
BR112021021718A2 (pt) 2022-01-18
US20210355112A1 (en) 2021-11-18
SG11202111552YA (en) 2021-11-29
JP2025011262A (ja) 2025-01-23
AU2020267576B2 (en) 2025-03-13
MD3965884T2 (ro) 2025-05-31
TWI855068B (zh) 2024-09-11
CL2021002883A1 (es) 2022-10-28

Similar Documents

Publication Publication Date Title
HUE070650T2 (hu) Dioxo-1,2,4-triazil fejcsoportot tartalmazó THR-béta modulátorok
CA201845S (en) Toothbrush head
CA186417S (en) Toothbrush head
CA207118S (en) Oral irrigator
CA193485S (en) Oral irrigator
CA195311S (en) Toothbrush
EP4082388A4 (en) TOOTHBRUSH
EP3888591A4 (en) ORAL IRRIGATOR
CA207116S (en) Toothbrush
GB2588957B (en) A cleaner head
CA193063S (en) Toothbrush
EP4082389A4 (en) TOOTHBRUSH
CA195883S (en) Toothbrush
GB2587428B (en) A ring buffer with multiple head pointers
PL3735823T3 (pl) Głowica usuwająca liście
GB201914539D0 (en) Print head
HK40029354A (en) Hammer head with interference fit
HK40029354B (en) Hammer head with interference fit
GB201918979D0 (en) A mouth swab
CA206245S (en) Toothbrush
CA196018S (en) Toothbrush
CA196017S (en) Toothbrush
CA196019S (en) Toothbrush
GB202007636D0 (en) A new typewriter
CA196012S (en) Toothbrush